Sumatriptan Tablet, Film Coated
Product Images NDC 69452-346

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 69452-346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sumatriptan Figure 1)

FDA Label Image

Figure 1 (Sumatriptan Figure 2)

FDA Label Image

Figure 2 (Sumatriptan Figure 3)

FDA Label Image

25 mg Label (Sumatriptan Figure 4)

25 mg Label (Sumatriptan Figure 4)
This text is not available as it contains random characters and does not form any useful description.*
FDA Label Image

50 mg Label (Sumatriptan Figure 5)

50 mg Label (Sumatriptan Figure 5)
This is a product label for Sumatriptan Tablets, USP which come in a blister of 9 film-coated tablets. The medication is used to treat migraine headaches and the dosage should be followed as per physician's instructions. The tablets should be stored between 20-25°C and kept out of reach of children. The packaging also includes safety information, NDC number and dispense guidelines for pharmacists.*
FDA Label Image

100 mg Label (Sumatriptan Figure 6)

100 mg Label (Sumatriptan Figure 6)
This is a package of Sumatriptan Tablets, USP with 9 film-coated tablets per blister. Each tablet contains 100mg of sumatriptan. The tablets are manufactured by Bionpharma and have the imprint "91iim" and "100" on them. The package has an NDC number of 69452-346-72. It is recommended that the pharmacist dispense the patient information leaflet with the drug product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.